Collegium Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.

About COLL

Collegium Pharmaceutical, Inc. is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. The firm has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions. 

CEO
Vikram Karnani
CEOVikram Karnani
Employees
423
Employees423
Headquarters
Stoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded
2002
Founded2002
Employees
423
Employees423

COLL Key Statistics

Market cap
747.15M
Market cap747.15M
Price-Earnings ratio
19.04
Price-Earnings ratio19.04
Dividend yield
—
Dividend yield—
Average volume
676.37K
Average volume676.37K
High today
$23.49
High today$23.49
Low today
$22.15
Low today$22.15
Open price
$23.30
Open price$23.30
Volume
645.24K
Volume645.24K
52 Week high
$50.79
52 Week high$50.79
52 Week low
$21.43
52 Week low$21.43

Stock Snapshot

As of today, Collegium Pharmaceutical(COLL) shares are valued at $22.96. The company's market cap stands at 747.15M, with a P/E ratio of 19.04.

On 2026-10-23, Collegium Pharmaceutical(COLL) stock traded between a low of $22.15 and a high of $23.49. Shares are currently priced at $22.96, which is +3.7% above the low and -2.3% below the high.

Collegium Pharmaceutical(COLL) shares are trading with a volume of 645.24K, against a daily average of 676.37K.

During the past year, Collegium Pharmaceutical(COLL) stock moved between $21.43 at its lowest and $50.79 at its peak.

During the past year, Collegium Pharmaceutical(COLL) stock moved between $21.43 at its lowest and $50.79 at its peak.

COLL News

TipRanks 4d
Collegium Pharmaceutical Settles Nucynta ER Patent Dispute

Collegium Pharmaceutical ( (COLL) ) has issued an announcement. On October 15, 2026, Collegium Pharmaceutical and Grünenthal GmbH entered into a settlement agr...

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.